Barely Significant
← all excerpts

<i>IRF8</i> and <i>CD2</i> are potential targets of immunotherapy in non-small cell lung cancer.

J Thorac Dis · 2025 · PMC11986741 · PMID 40223995

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

showed a trendno p-value reported
As expected, ARHGAP15 , CD2 , GIMAP5 , and IRF8 were protective factors and showed a trend of downregulation in expression with increasing risk score, while DLGAP5 and FOXM1 genes were risk factors and showed an upregulation trend in expression with increasing risk score.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.